CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- 4 Grant or award CEO and President acquired 840,274 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 168,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award 10% owner acquired 2,203,869 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Conversion Former Director and 10% Owner acquired 126,645 shares (conversion)
- 4 Conversion Former 10% Owner acquired 126,645 shares (conversion)
- 4 Conversion Director acquired 703,588 shares (conversion)
- 4 Gift SVP and Chief Medical Officer gave 22,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Senior VP of Commercial acquired 4,117 shares (grant or award)
- 4 Grant or award VP, Legal and Secretary acquired 2,448 shares (grant or award)
- 4 Grant or award Sr VP, CFO, Treasr, Asst Secy acquired 2,448 shares (grant or award)
Page 12 of 20 · 382 filings